Properties (14)

Id 5f0dea96-5258-4bdb-bc09-f20febb3fc51

Year 2023

Abstract

Cssclasses

purpleRed

Aliases

(Mattson et al., 2023)

Import Date 01-24-2026

Zotero Note Link Generated true

Checked For Zettle Notes true

Dv Authors Seth A. Mattson, Johann D'Souza, Katharine D. Wojcik, Andrew G. Guzick, Wayne K. Goodman, Eric A. Storch,

Dv Initial Source Misophonia MOCMisophonia

Dv Status #status/Bare-bones-review

Dv Limitations • Scarcity of RCTs and high reliance on case studies. • Small sample sizes, heterogeneity in interventions and outcome measures. • Lack of consensus on diagnostic criteria and standard outcome metrics. • Predominant use of self-report; clinician-administered scales underutilized.

Dv Future Directions • Develop and test mechanism-based treatment protocols with stakeholder input. • Conduct dismantling studies to isolate effective components. • Replicate promising interventions in independent samples. • Improve measurement tools (validity, clinician-administered scales). • Expand research on third-wave and pharmacological treatments.

Dv Relevance • a literature review of treatment approaches to Misophonia up to 2023 • found a lot of what we already expected, with CBT being the most used and successful. they also discuss CBT with exposure to mixed results. • a good source for spinning someone up on the (as of this article) current treatment attempts.

•

A systematic review of treatments for misophonia

Status:: #status/Bare-bones-review

Metadata

Item Type: #journalArticle
Authors:: Seth A. Mattson, Johann D'Souza, Katharine D. Wojcik, Andrew G. Guzick, Wayne K. Goodman, Eric A. Storch,
Date:
Date Added: 1683865760000
URL: https://linkinghub.elsevier.com/retrieve/pii/S2468171723000054
DOI: 10.1016/j.pmip.2023.100104
Cite Key: mattsonSystematicReviewTreatments2023
Topics: [object Object]
Tags:: #Bare-bones-review-🦴 , #Misophonia, #literature-review, #treatment, #CBT, #assessment,
PDF Attachments

Abstract


Background/Purpose	Background- • Misophonia was first formally named in 2002 and typically presents in childhood/adolescence. • Triggers are most often oral/nasal sounds (e.g., chewing, breathing), producing intense emotional and autonomic reactions. • Common comorbidities include depression, anxiety, OCD, ADHD, autism, and suicidality. • Functional neuroimaging implicates hyperconnectivity between auditory and motor circuits (e.g., anterior insula). • Despite increasing recognition, treatment research is in early stages and lacks methodological rigor. Purpose- • To systematically review all peer-reviewed treatments specifically targeting misophonia symptoms. • Identify the effectiveness of different treatment modalities and assess trends in the literature to inform clinical practice and future research.
Participants/samples	• 33 studies included: 1 RCT, 1 open-label trial, and 31 case studies/series. • Wide age range and diverse comorbidity profiles. • Inclusion required English-language full-text studies focusing on misophonia as a primary or secondary treatment target.
Measures	N/A
Procedures	N/A
Results	• CBT: • Most studied and most effective across modalities. • RCT by Jager et al. (2020): group CBT led to a 9.7-point AMISOS-R reduction (d = 1.97); 37% were treatment responders. • Open-label trial: 90 patients, 48% with ≥30% reduction in A-MISO-S. • CBT with exposure therapy: • Mixed outcomes; some show strong benefit, others show no change. • Exposure integrated into broader CBT or as graded/inhibitory learning models. • One case (Dover & McGuire): 70% symptom reduction, 75% reduction in family accommodation behaviors. • Third-wave therapies: • ACT and DBT showed positive outcomes in isolated cases, targeting emotion regulation and acceptance. • Example: DBT led to A-MISO-S reduction from 22 to 10 over 7 weeks. • TRT: • Jastreboff studies showed ~86% self-reported improvement. • One case showed AMISOS-R decrease from 17 to 6 after 28 weeks. • Pharmacotherapy: • SSRIs (fluoxetine, sertraline, escitalopram) yielded partial to full remission in some cases. • Propranolol reduced autonomic arousal symptoms (e.g., A-MISO-S drop from 15 to 2). • Risperidone improved symptoms in a child with autism. • Methylphenidate combined with CBT helped in ADHD comorbidity.
Discussion/Limits	Conclusion- • CBT, especially group-based, is the most promising treatment, with moderate to large effect sizes in the RCT. • The field lacks clarity on which components (e.g., exposure, relaxation, cognitive reappraisal) are most effective. • Exposure-based approaches may benefit from inhibitory learning models rather than habituation. • Preliminary evidence supports ACT, DBT, and pharmacological interventions in specific contexts.
Limitations::	• Scarcity of RCTs and high reliance on case studies. • Small sample sizes, heterogeneity in interventions and outcome measures. • Lack of consensus on diagnostic criteria and standard outcome metrics. • Predominant use of self-report; clinician-administered scales underutilized.
Future Directions::	• Develop and test mechanism-based treatment protocols with stakeholder input. • Conduct dismantling studies to isolate effective components. • Replicate promising interventions in independent samples. • Improve measurement tools (validity, clinician-administered scales). • Expand research on third-wave and pharmacological treatments.
Relevance::	• a literature review of treatment approaches to Misophonia up to 2023 • found a lot of what we already expected, with CBT being the most used and successful. they also discuss CBT with exposure to mixed results. • a good source for spinning someone up on the (as of this article) current treatment attempts.

key terms

Misophonia – A condition marked by decreased tolerance to specific auditory stimuli (“triggers”) leading to intense negative emotional, physiological, and behavioral reactions, including anger, disgust, anxiety, and autonomic arousal.
Cognitive Behavioral Therapy (CBT) – A psychological intervention aiming to restructure maladaptive thought patterns and behaviors; in misophonia, often includes counter-conditioning, task concentration, and arousal reduction.
Counter-conditioning – A behavioral technique where a negative trigger (e.g., chewing sound) is paired with a positive stimulus to elicit a new, more adaptive emotional response.
Exposure Therapy – A behavioral technique involving gradual exposure to feared or avoided stimuli to reduce associated distress; in misophonia, used to reduce reactivity to trigger sounds.
Third-wave behavioral therapies – Therapies like Acceptance and Commitment Therapy (ACT) and Dialectical Behavior Therapy (DBT) that emphasize mindfulness, acceptance, and values-based action.
Tinnitus Retraining Therapy (TRT) – A therapy involving sound exposure and habituation, adapted for misophonia to reduce distress toward trigger noises.
Amsterdam Misophonia Scale (A-MISO-S) – A clinician-administered scale modeled on the Y-BOCS to measure misophonia severity.
AMISOS-R – Revised self-report version of the A-MISO-S with improved psychometric properties.
CGI-I – Clinical Global Impression-Improvement scale, a one-item measure assessing clinician-rated improvement over time.

my engagement notes

my questions

my comments

Bookmarks

bookmark for Cognitive-Behavioral therapy (page 5)
bookmark for CBT with exposure therapy (page 5)
bookmark for talking about “Third-Wave” therapy approaches (page 9)
bookmark for Pharmacotherapy (page 9)

reading notes

Heterogeneity in Treatment Responses

Interventions worked variably depending on symptom severity, age, comorbidities, and modality (e.g., virtual vs. in-person).

Importance of Family Involvement

Several successful protocols incorporated family education or behavioral coaching (e.g., parent management training).

Need for Stakeholder Engagement

Authors emphasize participatory research approaches to improve real-world implementation and ecological validity.

zettelkasten

Mattson 2023 on CBT and treatment outcomes in Misophonia